Excepgen
YC W19San Francisco, US · 3 employees · 4 known investors
ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.
Also known as Excepgen INC
AI & Machine LearningBiotechHealthtechUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (W19)
TF
Thomas FolliardinFounder
Investors · 4
Competitors · 3
by search overlapBiogen Idec5 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Macrogenics Inc5 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
PepGen3 shared keywordsPepGen develops disease-modifying therapeutics aimed at the underlying causes of serious genetic neuromuscular and neurological diseases. The company is building a pipeline of oligonucleotide-based treatments for these conditions.
Companies competing with Excepgen for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Excepgen do?
- ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.
- Who founded Excepgen?
- Excepgen was founded by Thomas Folliard.
- Who are Excepgen's investors?
- Excepgen's investors include Oxonian Ventures, Pi Campus, Y Combinator, ZAKA VC.
- Where is Excepgen headquartered?
- Excepgen is headquartered in San Francisco, US.